View Single Post
Old 06-10-2014, 03:43 PM
anagirl anagirl is offline
Member
 
Join Date: Aug 2012
Location: San Francisco
Posts: 199
10 yr Member
anagirl anagirl is offline
Member
 
Join Date: Aug 2012
Location: San Francisco
Posts: 199
10 yr Member
Default FDA Approves Expanded Label for Teva Parkinson’s Drug

Teva Pharmaceutical Industries Ltd. announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Azilect (rasagiline tablets) from monotherapy and adjunct to levodopa (LD) to now include adjunct to dopamine agonists (DAs). The new indication reflects that Azilect can be used alone or in combination with other Parkinson’s disease (PD) medications. The approval reinforces the growing clinical evidence demonstrating the benefit of Azilect across all stages of PD.



http://www.dddmag.com/news/2014/06/f...4&location=top
anagirl is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (06-10-2014), Tupelo3 (06-10-2014)